ENTPD1 and glioma: CD3 on CD39( +) resting Treg cells combined with Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels jointly reduce glioma risk(ME = − 0.0259, MP = 7.9%) (Table 1).